[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335172-105":59,"doc-detail-335172-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","characterization-of-commercially-available-murine-fibrosarcoma-nctc-2472-cells-both-in-vitro-and-as-a-model-of-bone-cancer-pain-in-vivo","Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo","","Cancer-induced bone pain lowers quality of life by driving severe, often neuropathic pain linked to tumor metastasis to bone. To support symptom management and therapeutic development, this study characterizes the commercially available murine fibrosarcoma cell line NCTC-2472 in vitro and evaluates its use in vivo. Dimethyl sulfoxide reduced NCTC-2472 viability in a dose-dependent manner. After implantation into syngeneic C3H/HeJ mice, tumors produced mechanical allodynia without thermal hyperalgesia. Gabapentin reversed mechanical allodynia in a dose-dependent way, establishing a refined CIBP model for anti-cancer and analgesic testing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characterization-of-commercially-available-murine-fibrosarcoma-nctc-2472-cells-both-in-vitro-and-as-a-model-of-bone-cancer-pain-in-vivo/335172/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characterization-of-commercially-available-murine-fibrosarcoma-nctc-2472-cells-both-in-vitro-and-as-a-model-of-bone-cancer-pain-in-vivo/335172.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of characterizing NCTC-2472 cells in this study?","Question",{"text":112,"@type":113},"To establish how the commercially available murine fibrosarcoma cell line NCTC-2472 can be used to evaluate novel compounds in vitro and to model cancer-induced bone pain in vivo.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study assess effects of dimethyl sulfoxide on NCTC-2472 cells?",{"text":117,"@type":113},"The study measured cell viability and found dimethyl sulfoxide decreased viability in a dose-related manner.",{"name":119,"@type":110,"acceptedAnswer":120},"What pain-related outcomes were observed after implanting NCTC-2472 into C3H/HeJ mice?",{"text":121,"@type":113},"Tumor development led to mechanical allodynia but not thermal hyperalgesia.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335172,1790686145,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","PLOS ONE  \nOPEN ACCESS  \nCitation: Ortiz YT, Shamir LG, McMahon LR, Wilkerson JL (2024) Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo. PLoS ONE 19(8): e0309398 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0309398  \nEditor: Mozaniel Santana de Oliveira, Museu Paraense Emilio Goeldi, BRAZIL  \nReceived: February 14, 2024  \nAccepted: August 12, 2024  \nPublished: August 29, 2024  \nCopyright: © 2024 Ortiz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All data files are available from the Open Science Framework database ([https://osf.io/vtgzy/?view_only=](https://osf.io/vtgzy/?view_only=)[ ](https://osf.io/vtgzy/?view_only=)[453646b4f7a549bfb4bbb616e4978319](453646b4f7a549bfb4bbb616e4978319)).  \nFunding: LRM-Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center startup funding. [https://www.ttuhsc.edu/](https://www.ttuhsc.edu/)[ ](https://www.ttuhsc.edu/)[institutional-advancement/funding-opportunities.](institutional-advancement/funding-opportunities.)[ ](institutional-advancement/funding-opportunities.)aspx Funding source did not play any role in study  \nRESEARCH ARTICLE  \nCharacterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo  \nYumaT. Ortiz1,2 *, Leila G. Shamir2, Lance R. McMahon2, Jenny L. Wilkerson2 *  \n1 Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America, 2 Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America  \n* [yuortiz@ttuhsc.edu](yuortiz@ttuhsc.edu) (YTO); [jenny.wilkerson@ttuhsc.edu](jenny.wilkerson@ttuhsc.edu) (JLW)  \nAbstract  \nFor many cancer patients tumor burden negatively impacts quality of life due to associated pain onset. Neuropathic pain is commonly associated with late cancer stages, and is resultant of tumor metastasis to bone, herein referred to as cancer-induced bone pain. Given the severe impact on quality of life and clinical treatment strategies focusing on symptom management, novel therapeutics are needed to alleviate cancer-induced bone pain and/or reduce cancer burden. In the current study we characterized a commercially available murine fibrosarcoma cell line, NCTC-2472 in vitro, which can be used to assess the capacity of novel compounds to impact cellular viability. We found that dimethyl sulfoxide, a known cytotoxic agent and common drug preparation compound, significantly decreased cell viability in a dose-related manner. We then characterized the in vivo tumor development and associated pain behavior characteristics following implantation of NCTC-2472 fibrosarcoma into male and female C3H/HeJ mice. The C3H/HeJ strain was utilized as these mice are syngeneic with NCTC-2472 fibrosarcoma and their use reduces potential implantation failure. We found that tumor development in mice resulted in the development of mechanical allodynia but not thermal hyperalgesia. Gabapentin, a clinically relevant analgesic, produced dose-related mechanical allodynia reversal. These studies provide further characterization of a cancer-induced bone pain model that can be used to examine novel compounds as anti-cancer and analgesic therapeutics.  \nIntroduction  \nSoft tissue sarcomas include a heterogenous family of tumors with a comparatively low incidence rate internationally, up to 5 cases per 100,000 individuals annually [ 1] . Despite accounting for \u003C 1% of all cancers, soft tissue sarcomas are highly metastatic, with an estimated 40% - 50% localized tumor (i.e., fibrosarcoma) patients having m","cbCaie7BAp4ixFcw","https://ap.wps.com/l/cbCaie7BAp4ixFcw","pdf",2629065,15,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main purpose of characterizing NCTC-2472 cells in this study?\",\"answer\":\"To establish how the commercially available murine fibrosarcoma cell line NCTC-2472 can be used to evaluate novel compounds in vitro and to model cancer-induced bone pain in vivo.\"},{\"question\":\"How did the study assess effects of dimethyl sulfoxide on NCTC-2472 cells?\",\"answer\":\"The study measured cell viability and found dimethyl sulfoxide decreased viability in a dose-related manner.\"},{\"question\":\"What pain-related outcomes were observed after implanting NCTC-2472 into C3H/HeJ mice?\",\"answer\":\"Tumor development led to mechanical allodynia but not thermal hyperalgesia.\"}]","Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo | PDF",1790009904,38]